Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved. Consult a licensed healthcare professional. See full disclaimer.
Understanding IGF-1 LR3
IGF-1 LR3 is a long-acting variant of insulin-like growth factor 1 with extended half-life and increased biological activity. Research demonstrates significant effects on muscle growth, fat loss, recovery, and anti-aging. Mechanisms operate through IGF-1 signaling pathways.
Key Mechanisms and Effects
IGF-1 LR3 activates the PI3K/Akt pathway, increases muscle protein synthesis, enhances glucose uptake, reduces muscle protein breakdown, and stimulates lipolysis. These mechanisms combine for powerful anabolic effects.
Administration and Dosing
Typical dosing ranges from 20-40 mcg daily via subcutaneous injection. Cycles typically last 8-12 weeks followed by break periods. Individual response varies significantly.
Results and Timeline
Initial improvements in recovery and pumps appear within 1-2 weeks. Muscle growth becomes visible by week 4-6. Maximum results typically appear by week 8-12. Results are dose and training dependent.
Stacking Considerations
IGF-1 LR3 stacks synergistically with testosterone, growth hormone, and other anabolic compounds. Each combination produces different results; consult research for optimal stacks.
Safety Profile
Research shows generally good tolerance at therapeutic doses. Side effects are typically mild and manageable. Long-term human safety data is limited.
Comparison with Other Growth Factors
IGF-1 LR3 differs from other growth factors in duration (extended half-life), potency (increased by 10x), and availability (research-only status). Direct comparison to other peptides depends on goals.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →Frequently Asked Questions
How much muscle can I gain with IGF-1 LR3?
Muscle gains of 4-8 kg lean mass over 12 weeks are typical with proper training and nutrition. Strength gains of 10-30% are common. Results vary based on baseline, training stimulus, and genetics.
What are the main side effects?
Common side effects include joint swelling, carpal tunnel symptoms, increased water retention, and mild hypoglycemia. Most resolve after cessation or dose adjustment.
How long does it take to work?
Improved recovery and pumps appear within 1-2 weeks. Visible muscle growth appears by week 4-6. Full effects typically apparent by week 8-12.
Can women use IGF-1 LR3?
Yes, women can use IGF-1 LR3. Results are similar to men but typically with smaller absolute muscle gains due to lower baseline testosterone. Benefits for body composition and recovery are substantial.
How does it compare to testosterone?
Different mechanisms: testosterone builds muscle through androgen receptor activation; IGF-1 works through growth factor pathways. Results are complementary; stacking produces synergistic effects.
Is IGF-1 LR3 legal?
Status varies by jurisdiction. Most are legal for research use; check local regulations. Not approved for human use by major health agencies.